Global Venturing Review

27 July 2020 – CureVac Officially Closes $640m Round

Informações:

Sinopsis

Deals CureVac has officially closed a $640m round, adding $126m to recent investments that included $171m from GlaxoSmithKline through a strategic partnership. That’s one of the biggest venture rounds ever in the life sciences sector, and the interest likely stems from the potential of its messenger RNA therapies to form the basis of a Covid-19 vaccine, … Continue reading "27 July 2020 – CureVac Officially Closes $640m Round"